Most longevity clinics in Dubai offer comprehensive metabolic and biological age markers but lack a standardized, clinically restrained method for cognitive baselining. This creates a gap where cognitive decline or performance optimization is managed through anecdotal patient reports rather than longitudinal data.
We deploy a lightweight reseller sequence: a web assessment, clinic order form, and consent flow that culminates in a branded PDF report. By bypassing the procurement gravity of large hospital groups and focusing on the longevity membership layer, we establish a diagnostic habit before moving toward deeper systems integration.
The pilot phase targets five clinics with a 50 patient paid trial. Wholesale pricing is set at 80 to 120 dollars per patient [est]. This figure is derived from the estimated cost of clinician review time plus the value of the proprietary baseline report relative to standard neuropsychological screenings.
Developed by [email protected] as part of the NOMOI portfolio. The focus is on asset light deployment and clinical restraint, ensuring the output is viewed as a medical tool rather than a wellness gimmick.